Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide

Eli Lilly filed lawsuits against pharmacies and peptide vendors over the sale of compounded versions of retatrutide, a weight-loss medication in development by the company. Some pharmacies and medical spas have been selling compounded retatrutide to consumers seeking access to the drug before its official approval and market release.

Next story